Back

RANDOMIZED TRIAL TO EVALUATE THE OPTIMAL NUMBER OF PASSES REQUIRED FOR MOLECULAR PROFILING DURING ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE BIOPSY OF PANCREATIC ADENOCARCINOMA

RANDOMIZED TRIAL TO EVALUATE THE OPTIMAL NUMBER OF PASSES REQUIRED FOR MOLECULAR PROFILING DURING ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE BIOPSY OF PANCREATIC ADENOCARCINOMA

  • Clinical Trial Information

    Trial Contact: Garcia de Djuro, Ginette

    Trial Phone: 321.841.6649

  • IRB No: 21.069.05

    Protocol Abbrev: Pan Ca-Mol

    Principal Investigator: Ji Young Bang, MD

    Age Group: Adult

    Treatment: EUS-guided Fine Needle Biopsy

    Therapies Involved: Surgery

  • Objective

    The primary outcome measure is to compare the rate of procurement of biopsy specimen adequate for molecular profiling between two vs. three passes during EUS-FNB of pancreatic cancer.

  • Key Eligibility

    1. Age ≥ 18 years
    2. Suspected or confirmed pancreatic mass seen on imaging, requiring EUS-FNB